Intensive combination immunosuppressive therapy with glucocorticoids and immunosuppressive agents has been used to treat patients with anti‐MDA5 antibody‐positive CADM with rapidly progressive interstitial pneumonitis [3]. Here, IFIH1 is linked to Interstitial pneumonitis.